Synovo raised €13 million with Lauxera Capital Partners in France
18 September 2024
18 September 2024
Total investments received (USD): 14.3M
Round value (USD): 14.3M
Round investors: Lauxera Capital Partners
Company: Synovo
Related deals
May health in a €10M series B extension led by Nexpring Health, joined by existing shareholders Sofinnova Partners, Bpifrance, and Trill Impact.
Investments
02 March 2026
4Moving Biotech raised a €12 million financing with 4P-Pharma, Fondation Arthritis, SATT Lutech, Business Angels, Family Offices in France
Investments
17 January 2026
Apmonia Therapeutics raised €10M series A with Capital Grand Est, Finovam Gestion, Fondation Fournier-Majoie, Angels Santé, Capital Cell in France
Investments
09 January 2026
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
BrightHeart raised $12.8m Series A funding co-led by Odyssée Venture and GO Capital, joined by and Sofinnova Partners, Mussallem, Lift Value, Side Angels
Investments
08 December 2025
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
United Kingdom